Astrocyte–immune cell co-cultures

LS Liliana M. Sanmarco
MW Michael A. Wheeler
CG Cristina Gutiérrez-Vázquez
CP Carolina Manganeli Polonio
ML Mathias Linnerbauer
FP Felipe A. Pinho-Ribeiro
ZL Zhaorong Li
FG Federico Giovannoni
KB Katelyn V. Batterman
GS Giulia Scalisi
SZ Stephanie E. J. Zandee
EH Evelyn S. Heck
MA Moneera Alsuwailm
DR Douglas L. Rosene
BB Burkhard Becher
IC Isaac M. Chiu
AP Alexandre Prat
FQ Francisco J. Quintana
ask Ask a question
Favorite

Naive CD4+ T cells and NK cells were isolated from the spleens of B6.SJL-Ptprca Pepcb/BoyJ mice (The Jackson Laboratory, 002014) or IfngEYFP reporter mice using Miltenyi beads (130-104-453 and 130-115-818). CD4+ T cells were activated overnight with 10 μg ml−1 anti-CD3 (bioXcell, BE0001-1-A005mg) and 0.25 μg ml−1 anti-CD28 (bioXcell, BE0015-5-A005mg). For co-culture with EAE T cells, T cells were isolated from mice undergoing EAE at the peak of disease by flow cytometry based on CD3, CD4, and DR5 expression. DR5+ and DR5 T cells were isolated separately for co-culture. Astrocytes and CD4+ T cells cells were co-cultured in a 2:1 ratio. To block TRAIL, astrocytes were treated with IFNγ overnight, washed extensively with 1× PBS, and 2.5 μg ml−1 of anti-TRAIL antibody (Thermo Fisher Scientific, 16-5951-85) or isotype control antibody (Thermo Fisher Scientific, 16-4321-81). Astrocytes were incubated with antibodies for one hour before addition of activated CD4+ T cells. In another set of experiments CD4+ T cells were activated with anti-CD3 and anti-CD28 as described above for 72 h and NK cells were activated with 100 ng ml−1 LPS (Invivogen, tlrl-3pelps) for 48 h. IfngYFP+ and IfngYFP− cells were sorted and co-cultured with astrocytes. After 8 h of co-culture, cells were collected for FACS. Cell-surface antibodies were added for 30 min on ice, cells were washed and fixed to detect active-caspase-3 as described above. For TUNEL (Abcam, ab66108) staining, cells were fixed in 1% v/v PFA for 15 min on ice, washed with 1× PBS and incubated with 70% ethanol for 30 min on ice and washed twice. Cells were stained with staining solution (10 μl of reaction buffer, 0.75 μl of TdT enzyme, 8 μl of FITC-dUTP and 32.25 μl of water) for 60 min at 37 °C, washed and acquired on LSR Fortessa (BD Biosciences) or Symphony A5 (BD Biosciences). Antibodies used were: BV711 anti-mouse CD45.1 (BD Biosciences, 747742, 1:100), PE/Dazzle594 anti-CD11b (Biolegend, 101256, 1:100), PE anti-mouse CD3 (Biolegend, 100206, 1:100), BV650 anti-mouse CD4 (Biolegend, 100546, 1:100), PerCP-Vio700 anti-mouse DR5 (Miltenyi, MD5-1-3C2, 1:10), APC-Cy7 anti-IFNγ (BD Biosciences, 561479, 1:100), PE anti-mouse IL-17A (eBioscience, 12-7177-81, 1:100), BUV395 anti-mouse LAMP1, PE-Cy7 anti-mouse TRAIL, BUV661 anti-mouse CD45, BV786 anti-mouse CD11b, BV421 anti-mouse NK1.1 and BV750 anti-CD3.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A